PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION
Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (51)
- Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis. 2025-08-29 · Expand citations
- Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression. 2025-07-01 · Expand citations
- Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care. 2025-01-01 · Expand citations
- Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis 2024-10-03 · Expand citations
- Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial. 2024-10-01 · Expand citations
- Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis. 2024-04-01 · Expand citations
- Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. 2024-03-08 · Expand citations
- Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder. 2024-01-01 · Expand citations
- Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model. 2023-12-01 · Expand citations
- Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication. 2023-09-01 · Expand citations
- Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. 2023-04-14 · Expand citations
- Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. 2023-02-01 · Expand citations
- Efficacy and Safety of Psychedelics in Treating Anxiety Disorders. 2023-01-01 · Expand citations
- Group psychedelic therapy: empirical estimates of cost-savings and improved access. 2023-01-01 · Expand citations
- Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. 2023-01-01 · Expand citations
- Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. 2022-11-15 · Expand citations
- Increased global integration in the brain after psilocybin therapy for depression. 2022-04-01 · Expand citations
- Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. 2022-02-01 · Expand citations
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
- Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
- OpenAlex W2030224179
- OpenAlex W2062101624
- OpenAlex W2113099805
- OpenAlex W2996555671
- OpenAlex W3192281797
- OpenAlex W3203928800
- OpenAlex W3209277823
- OpenAlex W4213145592
- OpenAlex W4281666404
- OpenAlex W4297478109
- OpenAlex W4307093712
- OpenAlex W4311508922
- OpenAlex W4385628167
- OpenAlex W4386420994
- OpenAlex W4386894189
- OpenAlex W4387521434
- OpenAlex W4388447053
- OpenAlex W4388732506
- OpenAlex W4391842082
- OpenAlex W4393253405
- OpenAlex W4396814296
- OpenAlex W4396900907
- OpenAlex W4398780811
- OpenAlex W4399323719
- OpenAlex W4400099913
- OpenAlex W4402748917
- OpenAlex W4403775020
- OpenAlex W4404764894
- OpenAlex W4404930798
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.